NCT00371878View on ClinicalTrials.gov

Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

October 31, 2003

Conditions
PneumoniaMeningitisInvasive Pneumococcal DiseaseHIV
Interventions
BIOLOGICAL

7-valent pneumococcal conjugate vaccine (Prevnar)

Trial Locations (1)

BT3

Wellcome Trust Laboratories and Dept of Medicine, Queen Elizabeth Central Hospital, Blantyre

All Listed Sponsors
collaborator

Kamuzu University of Health Sciences

OTHER

collaborator

Liverpool School of Tropical Medicine

OTHER

collaborator

Wellcome Trust

OTHER

lead

Royal Liverpool University Hospital

OTHER_GOV

NCT00371878 - Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection | Biotech Hunter | Biotech Hunter